Impact of belatacept and tacrolimus on cytomegalovirus viral load control and relapse in moderate and high-risk cytomegalovirus serostatus kidney transplant recipients.
Wairimu MaguaAileen C JohnsonGeeta M KaradkheleIdelberto Raul BadellPayaswini VasanthAneesh K MehtaKirk A EasleyKenneth A NewellJoseph B RickertChristian P LarsenPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2022)
High-risk belatacept-treated recipients showed defects in sustaining viral control relative to tacrolimus-treated recipients. Avoidance of initial use belatacept in high-risk recipients or development of modified management protocols should be considered.